There’s something delightfully sci-fi about any kind of volumetric display. Sure, you know it’s not really a hologram, and Princess Leia isn’t about to pop out and tell you ...
The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.